U.S. markets closed
  • S&P 500

    4,280.15
    +72.88 (+1.73%)
     
  • Dow 30

    33,761.05
    +424.38 (+1.27%)
     
  • Nasdaq

    13,047.19
    +267.27 (+2.09%)
     
  • Russell 2000

    2,016.62
    +41.36 (+2.09%)
     
  • Crude Oil

    91.88
    -2.46 (-2.61%)
     
  • Gold

    1,818.90
    +11.70 (+0.65%)
     
  • Silver

    20.83
    +0.49 (+2.39%)
     
  • EUR/USD

    1.0257
    -0.0068 (-0.66%)
     
  • 10-Yr Bond

    2.8490
    -0.0390 (-1.35%)
     
  • GBP/USD

    1.2139
    -0.0064 (-0.52%)
     
  • USD/JPY

    133.4800
    +0.4810 (+0.36%)
     
  • BTC-USD

    24,565.50
    -165.46 (-0.67%)
     
  • CMC Crypto 200

    574.64
    +3.36 (+0.59%)
     
  • FTSE 100

    7,500.89
    +34.98 (+0.47%)
     
  • Nikkei 225

    28,546.98
    +727.65 (+2.62%)
     

New Strong Sell Stocks for October 8th

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

American Airlines Group Inc. AAL is a network air carrier. The Zacks Consensus Estimate for its current year earnings has been revised 1.7% downward over the last 30 days.

Cantel Medical Corp. CMD is a provider of infection prevention and control products and services for the healthcare market. The Zacks Consensus Estimate for its current year earnings has been revised 10.9% downward over the last 30 days.

CURO Group Holdings Corp. CURO is a provider of consumer finance to underbanked consumers in the United States, Canada, and the United Kingdom. The Zacks Consensus Estimate for its current year earnings has been revised 5.3% downward over the last 30 days.

DXC Technology Company DXC is a provider of information technology services and solutions. The Zacks Consensus Estimate for its current year earnings has been revised 0.9% downward over the last 30 days.

Entasis Therapeutics Holdings Inc. ETTX is a clinical-stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 3.6% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
American Airlines Group Inc. (AAL) : Free Stock Analysis Report
 
Cantel Medical Corp. (CMD) : Free Stock Analysis Report
 
DXC Technology Company. (DXC) : Free Stock Analysis Report
 
CURO Group Holdings Corp. (CURO) : Free Stock Analysis Report
 
Entasis Therapeutics Holdings Inc. (ETTX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.